Quantcast

Latest Clinical trial Stories

2014-10-22 12:29:36

WASHINGTON, Oct. 22, 2014 /PRNewswire-USNewswire/ -- ALS ACT, The ALS Association, and the Translational Research Advancing Therapy ALS (TREAT ALS(TM)) Northeast ALS Consortium (NEALS) clinical trials network are pleased to announce a call for phase II clinical trial applications for novel, high-potential treatments in amyotrophic lateral sclerosis (ALS). The call for clinical study proposals is directed toward academic-industry partnerships, including pharmaceutical,...

2014-10-22 08:31:07

NORWALK, Conn., Oct. 22, 2014 /PRNewswire/ -- Recently published clinical studies of Stretta for gastroesophageal reflux disease (GERD) have bolstered the already substantial database of evidence. This data has led to significantly expanded insurance coverage and adoption of Stretta therapy for sufferers of refractory GERD. The substantial body of clinical evidence supporting Stretta therapy as a safe and effective GERD treatment has driven new coverage policies that make Stretta...

2014-10-22 08:31:01

Results indicate Zalviso controlled moderate-to-severe acute pain following abdominal surgery better than placebo, with similar side effect profile REDWOOD CITY, Calif., Oct. 22, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that results from the IAP310 study have been published in Regional Anesthesia and Pain Medicine (RAPM), a peer-reviewed journal with broad, multidisciplinary readership. IAP310 was a randomized, placebo-controlled, Phase 3...

2014-10-22 00:21:42

-- Telotristat etiprate, a Phase 3 compound for the treatment of carcinoid syndrome PARIS and THE WOODLANDS, Texas, Oct. 22, 2014 /PRNewswire/ -- Ipsen (Euronext: IPN; ADR: IPSEY) and Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that they have entered into an exclusive licensing agreement for Ipsen to commercialize telotristat etiprate outside of North America and Japan, with a focus on the treatment of carcinoid syndrome. Lexicon retains sole rights to...

2014-10-21 23:09:06

Quorum Review IRB, the industry leader in central IRB services, announces Director of Regulatory Affairs and General Counsel Linda Coleman, JD, CIP, CHC, CHRC, as a presenter at MAGI’s 2014 Clinical Research Conference – West. Seattle, WA (PRWEB) October 21, 2014 Quorum Review IRB, the industry leader in central IRB services, announces Director of Regulatory Affairs and General Counsel Linda Coleman, JD, CIP, CHC, CHRC, as a presenter at MAGI’s 2014 Clinical Research Conference –...

2014-10-21 16:27:47

LONDON, Oct. 21, 2014 /PRNewswire/ -- Executive SummaryChina's regulatory framework for medical devices is undergoing radical changes. The country's new leaders have recognized that the regulations for supervision and administration of medical devices are far from perfect along with rapid population growth and thriving economy over the past 30 years. Chinese state council issued the latest "Regulations for the Supervision and Administration of Medical Devices" on February 12, 2014,...

2014-10-21 08:35:08

MENLO PARK, Calif., Oct. 21, 2014 /PRNewswire/ -- SRI Biosciences, a division of SRI International, has completed construction of an early-phase clinical trial facility in Plymouth, Michigan. The 9,400-square foot unit, located in the Michigan Life Science Innovation Center, is now open and fully equipped for early-stage human research studies of new medicines and medical devices. "SRI International's newest facility in Michigan means great news ahead--groundbreaking discoveries,...

2014-10-21 08:35:03

? eClinical Innovations to Be Showcased in San Diego, Barcelona, and Orlando ? NEWTOWN, Pa., Oct. 21, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical Solutions, today announced details of upcoming "Trial Blazer" User Conferences expected to draw hundreds of clinical trial professionals to exclusive customer events in Europe and the US. http://photos.prnewswire.com/prnvar/20130403/PH87647LOGO The first of these events will be...

2014-10-20 08:33:33

LONDON, October 20, 2014 /PRNewswire/ -- Richmond Pharmacology has extended its capacity with an additional six-bed facility dedicated to screening and out-patient procedures for early phase studies in patients, complementing its existing 68-bed facility within Croydon University Hospital. (Photo: http://photos.prnewswire.com/prnh/20141013/709417-a ) (Photo: http://photos.prnewswire.com/prnh/20141013/709417-b ) The new facility is adaptable to...

2014-10-20 08:31:41

First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease MARLBOROUGH, Mass., Oct. 20, 2014 /PRNewswire/ -- As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation (NYSE: BSX) has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREMIER((TM)) Everolimus-Eluting Platinum...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related